Emergent Biosolutions
Price & Volume
Stats
See more52W Range | $3.84-$15.10 |
Market Cap | $290.1M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $1B |
Revenue Growth (YoY) | -29.6% |
Gross Profit (12 Mos) | $375.4M |
Diluted EPS | -$3.60 |
News
See moreYahoo Finance • yesterday
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health
Yahoo Finance • last month
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
Yahoo Finance • last month
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
About
CFO | Mr. Richard S. Lindahl M.B.A. |
Address | 300 Professional Drive, Gaithersburg, MD, United States, 20879 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 900 |
